Next Generation Sequencing Market 2023-2027

The next generation sequencing market is forecasted to grow by USD 3409.76 mn during 2022-2027, accelerating at a CAGR of 12.45% during the forecast period. The report on the next generation sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased utilization of NGS methods, growing demand for early diagnosis of genetic disorders, and availability of wide range of NGS products.

The next generation sequencing market is segmented as below:

By End-user

Academic research
Clinical research
Pharma & biotech companies
Others

By Product

Consumables
Equipment

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advances in NGS techniques as one of the prime reasons driving the next generation sequencing market growth during the next few years. Also, reduced costs of gene sequencing and developments in bioinformatics and cloud-based software programs will lead to sizable demand in the market.

The report on the next generation sequencing market covers the following areas:

Next generation sequencing market sizing
Next generation sequencing market forecast
Next generation sequencing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading next generation sequencing market vendors that include 10X Genomics Inc., Azenta Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Konica Minolta Inc., Laboratory Corp. of America Holdings, Merck KGaA, Nabsys Inc., OPKO Health Inc., Oxford Nanopore Technologies plc, Perkin Elmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Standard BioTools Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.. Also, the next generation sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global next generation sequencing market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global next generation sequencing market 2017 - 2021 ($ million)
4.2 End-user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Academic research - Market size and forecast 2022-2027
Exhibit 34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
6.4 Clinical research - Market size and forecast 2022-2027
Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
Exhibit 42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by End-user
Exhibit 50: Market opportunity by End-user ($ million)
Exhibit 51: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 52: Chart on Product - Market share 2022-2027 (%)
Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 54: Chart on Comparison by Product
Exhibit 55: Data Table on Comparison by Product
7.3 Consumables - Market size and forecast 2022-2027
Exhibit 56: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Consumables - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
7.4 Equipment - Market size and forecast 2022-2027
Exhibit 60: Chart on Equipment - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Equipment - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Equipment - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Equipment - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 64: Market opportunity by Product ($ million)
Exhibit 65: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 10X Genomics Inc.
Exhibit 115: 10X Genomics Inc. - Overview
Exhibit 116: 10X Genomics Inc. - Product/Service
Exhibit 117: 10X Genomics Inc. - Key offerings
12.4 Azenta Inc.
Exhibit 118: Azenta Inc. - Overview
Exhibit 119: Azenta Inc. - Business segments
Exhibit 120: Azenta Inc. - Key offerings
Exhibit 121: Azenta Inc. - Segment focus
12.5 BGI Genomics Co. Ltd.
Exhibit 122: BGI Genomics Co. Ltd. - Overview
Exhibit 123: BGI Genomics Co. Ltd. - Product/Service
Exhibit 124: BGI Genomics Co. Ltd. - Key offerings
12.6 Bio Rad Laboratories Inc.
Exhibit 125: Bio Rad Laboratories Inc. - Overview
Exhibit 126: Bio Rad Laboratories Inc. - Business segments
Exhibit 127: Bio Rad Laboratories Inc. - Key news
Exhibit 128: Bio Rad Laboratories Inc. - Key offerings
Exhibit 129: Bio Rad Laboratories Inc. - Segment focus
12.7 Eurofins Scientific SE
Exhibit 130: Eurofins Scientific SE - Overview
Exhibit 131: Eurofins Scientific SE - Business segments
Exhibit 132: Eurofins Scientific SE - Key news
Exhibit 133: Eurofins Scientific SE - Key offerings
Exhibit 134: Eurofins Scientific SE - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Illumina Inc.
Exhibit 140: Illumina Inc. - Overview
Exhibit 141: Illumina Inc. - Business segments
Exhibit 142: Illumina Inc. - Key news
Exhibit 143: Illumina Inc. - Key offerings
Exhibit 144: Illumina Inc. - Segment focus
12.10 Konica Minolta Inc.
Exhibit 145: Konica Minolta Inc. - Overview
Exhibit 146: Konica Minolta Inc. - Business segments
Exhibit 147: Konica Minolta Inc. - Key news
Exhibit 148: Konica Minolta Inc. - Key offerings
Exhibit 149: Konica Minolta Inc. - Segment focus
12.11 Laboratory Corp. of America Holdings
Exhibit 150: Laboratory Corp. of America Holdings - Overview
Exhibit 151: Laboratory Corp. of America Holdings - Business segments
Exhibit 152: Laboratory Corp. of America Holdings - Key news
Exhibit 153: Laboratory Corp. of America Holdings - Key offerings
Exhibit 154: Laboratory Corp. of America Holdings - Segment focus
12.12 Merck KGaA
Exhibit 155: Merck KGaA - Overview
Exhibit 156: Merck KGaA - Business segments
Exhibit 157: Merck KGaA - Key news
Exhibit 158: Merck KGaA - Key offerings
Exhibit 159: Merck KGaA - Segment focus
12.13 Perkin Elmer Inc.
Exhibit 160: Perkin Elmer Inc. - Overview
Exhibit 161: Perkin Elmer Inc. - Business segments
Exhibit 162: Perkin Elmer Inc. - Key news
Exhibit 163: Perkin Elmer Inc. - Key offerings
Exhibit 164: Perkin Elmer Inc. - Segment focus
12.14 QIAGEN NV
Exhibit 165: QIAGEN NV - Overview
Exhibit 166: QIAGEN NV - Product/Service
Exhibit 167: QIAGEN NV - Key news
Exhibit 168: QIAGEN NV - Key offerings
12.15 Standard BioTools Inc.
Exhibit 169: Standard BioTools Inc. - Overview
Exhibit 170: Standard BioTools Inc. - Product/Service
Exhibit 171: Standard BioTools Inc. - Key news
Exhibit 172: Standard BioTools Inc. - Key offerings
12.16 Takara Bio Inc.
Exhibit 173: Takara Bio Inc. - Overview
Exhibit 174: Takara Bio Inc. - Business segments
Exhibit 175: Takara Bio Inc. - Key offerings
Exhibit 176: Takara Bio Inc. - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 177: Thermo Fisher Scientific Inc. - Overview
Exhibit 178: Thermo Fisher Scientific Inc. - Business segments
Exhibit 179: Thermo Fisher Scientific Inc. - Key news
Exhibit 180: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 181: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 182: Inclusions checklist
Exhibit 183: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 184: Currency conversion rates for US$
13.4 Research methodology
Exhibit 185: Research methodology
Exhibit 186: Validation techniques employed for market sizing
Exhibit 187: Information sources
13.5 List of abbreviations
Exhibit 188: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global next generation sequencing market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on End-user - Market share 2022-2027 (%)
Exhibits 31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 50: Market opportunity by End-user ($ million)
Exhibits 51: Data Table on Market opportunity by End-user ($ million)
Exhibits 52: Chart on Product - Market share 2022-2027 (%)
Exhibits 53: Data Table on Product - Market share 2022-2027 (%)
Exhibits 54: Chart on Comparison by Product
Exhibits 55: Data Table on Comparison by Product
Exhibits 56: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Consumables - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Equipment - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Equipment - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Equipment - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Equipment - Year-over-year growth 2022-2027 (%)
Exhibits 64: Market opportunity by Product ($ million)
Exhibits 65: Data Table on Market opportunity by Product ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2022 and 2027
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: 10X Genomics Inc. - Overview
Exhibits 116: 10X Genomics Inc. - Product/Service
Exhibits 117: 10X Genomics Inc. - Key offerings
Exhibits 118: Azenta Inc. - Overview
Exhibits 119: Azenta Inc. - Business segments
Exhibits 120: Azenta Inc. - Key offerings
Exhibits 121: Azenta Inc. - Segment focus
Exhibits 122: BGI Genomics Co. Ltd. - Overview
Exhibits 123: BGI Genomics Co. Ltd. - Product/Service
Exhibits 124: BGI Genomics Co. Ltd. - Key offerings
Exhibits 125: Bio Rad Laboratories Inc. - Overview
Exhibits 126: Bio Rad Laboratories Inc. - Business segments
Exhibits 127: Bio Rad Laboratories Inc. - Key news
Exhibits 128: Bio Rad Laboratories Inc. - Key offerings
Exhibits 129: Bio Rad Laboratories Inc. - Segment focus
Exhibits 130: Eurofins Scientific SE - Overview
Exhibits 131: Eurofins Scientific SE - Business segments
Exhibits 132: Eurofins Scientific SE - Key news
Exhibits 133: Eurofins Scientific SE - Key offerings
Exhibits 134: Eurofins Scientific SE - Segment focus
Exhibits 135: F. Hoffmann La Roche Ltd. - Overview
Exhibits 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 137: F. Hoffmann La Roche Ltd. - Key news
Exhibits 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 140: Illumina Inc. - Overview
Exhibits 141: Illumina Inc. - Business segments
Exhibits 142: Illumina Inc. - Key news
Exhibits 143: Illumina Inc. - Key offerings
Exhibits 144: Illumina Inc. - Segment focus
Exhibits 145: Konica Minolta Inc. - Overview
Exhibits 146: Konica Minolta Inc. - Business segments
Exhibits 147: Konica Minolta Inc. - Key news
Exhibits 148: Konica Minolta Inc. - Key offerings
Exhibits 149: Konica Minolta Inc. - Segment focus
Exhibits 150: Laboratory Corp. of America Holdings - Overview
Exhibits 151: Laboratory Corp. of America Holdings - Business segments
Exhibits 152: Laboratory Corp. of America Holdings - Key news
Exhibits 153: Laboratory Corp. of America Holdings - Key offerings
Exhibits 154: Laboratory Corp. of America Holdings - Segment focus
Exhibits 155: Merck KGaA - Overview
Exhibits 156: Merck KGaA - Business segments
Exhibits 157: Merck KGaA - Key news
Exhibits 158: Merck KGaA - Key offerings
Exhibits 159: Merck KGaA - Segment focus
Exhibits 160: Perkin Elmer Inc. - Overview
Exhibits 161: Perkin Elmer Inc. - Business segments
Exhibits 162: Perkin Elmer Inc. - Key news
Exhibits 163: Perkin Elmer Inc. - Key offerings
Exhibits 164: Perkin Elmer Inc. - Segment focus
Exhibits 165: QIAGEN NV - Overview
Exhibits 166: QIAGEN NV - Product/Service
Exhibits 167: QIAGEN NV - Key news
Exhibits 168: QIAGEN NV - Key offerings
Exhibits 169: Standard BioTools Inc. - Overview
Exhibits 170: Standard BioTools Inc. - Product/Service
Exhibits 171: Standard BioTools Inc. - Key news
Exhibits 172: Standard BioTools Inc. - Key offerings
Exhibits 173: Takara Bio Inc. - Overview
Exhibits 174: Takara Bio Inc. - Business segments
Exhibits 175: Takara Bio Inc. - Key offerings
Exhibits 176: Takara Bio Inc. - Segment focus
Exhibits 177: Thermo Fisher Scientific Inc. - Overview
Exhibits 178: Thermo Fisher Scientific Inc. - Business segments
Exhibits 179: Thermo Fisher Scientific Inc. - Key news
Exhibits 180: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 181: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 182: Inclusions checklist
Exhibits 183: Exclusions checklist
Exhibits 184: Currency conversion rates for US$
Exhibits 185: Research methodology
Exhibits 186: Validation techniques employed for market sizing
Exhibits 187: Information sources
Exhibits 188: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global next generation sequencing market: 10X Genomics Inc., Azenta Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Konica Minolta Inc., Laboratory Corp. of America Holdings, Merck KGaA, Nabsys Inc., OPKO Health Inc., Oxford Nanopore Technologies plc, Perkin Elmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Standard BioTools Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is advances in NGS techniques.'

According to the report, one of the major drivers for this market is the increased utilization of NGS methods.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

10X Genomics Inc.
Azenta Inc.
BGI Genomics Co. Ltd.
Bio Rad Laboratories Inc.
Eurofins Scientific SE
F. Hoffmann La Roche Ltd.
Illumina Inc.
Konica Minolta Inc.
Laboratory Corp. of America Holdings
Merck KGaA
Nabsys Inc.
OPKO Health Inc.
Oxford Nanopore Technologies plc
Perkin Elmer Inc.
PierianDx Inc.
Psomagen Inc.
QIAGEN NV
Standard BioTools Inc.
Takara Bio Inc.
Thermo Fisher Scientific Inc.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2227EUR$2,500USD£1,938GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3563EUR$4,000USD£3,101GBP

The next generation sequencing market is segmented as below:

By End-user

By Product

By Geographical Landscape

The report on the next generation sequencing market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029

Next-Generation Sequencing Data Analysis Market - Global Forecast 2025-2032

Next-Generation Sequencing Sample Preparation Market - Global Forecast 2025-2032

Next-Generation Sequencing (NGS) Market Report 2025-2033

Next Generation Sequencing Market Report 2025-2035